Stocktoria
ENDRA Life Sciences Inc. NDRA
ENDRA Life Sciences Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $0 | $0 | $6,174 | $351,622 | $515,582 |
| Gross profit | — | — | — | — | — | $0 | $0 | $6,174 | $178,840 | $279,704 |
| R&D expense | $1.8M | $3.2M | $5.0M | $6.6M | $5.5M | $5.9M | $6.6M | $4.7M | $1.9M | $495,377 |
| Operating income | -$5.8M | -$10.8M | -$10.5M | -$13.2M | -$11.5M | -$11.5M | -$10.8M | -$9.0M | -$4.6M | -$1.8M |
| Interest expense | — | — | — | — | — | — | — | — | $42,633 | $71,988 |
| Income tax | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$7.0M | -$11.5M | -$10.1M | -$13.2M | -$11.2M | -$11.7M | -$13.3M | -$9.8M | -$5.4M | -$2.8M |
| EPS (diluted) | $-8.93 | $-56.94 | $-2766.85 | — | — | — | — | — | — | — |
| Operating cash flow | -$5.2M | -$7.4M | -$9.5M | -$12.8M | -$11.1M | -$10.7M | -$8.6M | -$7.7M | -$3.3M | -$1.3M |
| Free cash flow | -$5.2M | -$7.4M | -$9.6M | -$13.0M | -$11.2M | -$10.8M | -$8.6M | -$7.8M | -$3.3M | — |
| Cash & equivalents | — | — | — | $4.9M | $9.5M | — | — | — | — | — |
| Inventory | $0 | $0 | $2.6M | $2.6M | $1.3M | $589,620 | $113,442 | $59,444 | $191,680 | $40,105 |
| Total assets | $3.9M | $4.5M | $6.8M | $9.3M | $12.9M | $8.8M | $7.2M | $7.2M | $6.1M | $490,761 |
| Total liabilities | $1.6M | $1.9M | $1.1M | $2.1M | $2.1M | $1.6M | $2.4M | $974,583 | $848,214 | $1.4M |
| Shareholders' equity | $2.3M | $2.6M | $5.7M | $7.2M | $10.8M | $7.2M | $4.8M | $6.2M | $5.3M | -$893,767 |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | — | — | — | — | — | — | -100.0% | -98.2% | -31.8% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.